FIA
TEVA icon

FNY Investment Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

FNY Investment Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10
Closed – – 1052
2026
Q1 		$0 Buy
+10
New +$322 ﹤0.01% 1094
2025
Q4 		– Sell
-21,908
Closed -$442K – 1461
2025
Q3 		$442K Sell
21,908
-8,910
-29% -$156K 0.14% 174
2025
Q2 		$516K Buy
+30,818
New +$497K 0.22% 117
2022
Q2 		– Sell
-100
Closed – – 900
2022
Q1 		$0 Sell
100
-200
-67% -$1.67K ﹤0.01% 902
2021
Q4 		$2K Buy
+300
New +$2.71K ﹤0.01% 489
2021
Q3 		– Sell
-500
Closed -$4.68K – 923
2021
Q2 		$4K Buy
+500
New +$5.29K ﹤0.01% 655
2021
Q1 		– Sell
-900
Closed -$10.3K – 1003
2020
Q4 		$8K Buy
+900
New +$8.62K ﹤0.01% 607
2020
Q3 		– Sell
-50
Closed – – 603
2020
Q2 		$0 Buy
+50
New +$565 ﹤0.01% 592
2020
Q1 		– Sell
-100
Closed – – 800
2019
Q4 		$0 Hold
100
– – ﹤0.01% 1066
2019
Q3 		$0 Buy
+100
New +$766 ﹤0.01% 1173
2018
Q4 		– Sell
-9,900
Closed -$213K – 1011
2018
Q3 		$213K Buy
+9,900
New +$230K 0.05% 185

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

FNY Investment Advisers's TEVA Position: Q2 2026 in Review

FNY Investment Advisers sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 10 shares.

FNY Investment Advisers first reported a position in TEVA in Q3 2018 and held it in 11 quarters. The position peaked at $516K in Q2 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • FNY Investment Advisers reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • FNY Investment Advisers sold 10 Teva Pharmaceuticals shares in Q2 2026.
  • FNY Investment Advisers first reported a position in Teva Pharmaceuticals in Q3 2018 and held it in 11 quarters.
  • FNY Investment Advisers's Teva Pharmaceuticals position peaked at $516K in Q2 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.